Search tips
Search criteria 


Logo of capmcAbout manuscripts / A propos des manuscritsSubmit manuscript / soumettre un manuscrit
Blood. Author manuscript; available in PMC 2010 June 23.
Published in final edited form as:
PMCID: PMC2891006

Contributions of β2-microglobulin–dependent molecules and lymphocytes to iron regulation: insights from HfeRag1−/− and β2mRag1−/− double knock-out mice


Genetic causes of hereditary hemochromatosis (HH) include mutations in the HFE gene, coding for a β2-microglobulin (β2m)–associated major histocompatibility complex class I-like protein. However, iron accumulation in patients with HH can be highly variable. Previously, analysis of β2mRag1−/− double-deficient mice, lacking all β2m-dependent molecules and lymphocytes, demonstrated increased iron accumulation in the pancreas and heart compared with β2m single knock-out mice. To evaluate whether the observed phenotype in β2mRag1−/− mice was due solely to the absence of Hfe or to other β2m-dependent molecules, we generated HfeRag1−/− double-deficient mice. Our studies revealed that introduction of Rag1 deficiency in Hfe knock-out mice leads to heightened iron overload, mainly in the liver, whereas the heart and pancreas are relatively spared compared with β2mRag1−/− mice. These results suggest that other β2m-interacting protein(s) may be involved in iron regulation and that in the absence of functional Hfe molecules lymphocyte numbers may influence iron overload severity.


The protein involved in hereditary hemochromatosis (HH), HFE, has been identified as a β2-microglobulin (β2m)–dependent, major histocompatibility complex class I (MHC-I)–like molecule,1 complementing earlier findings that β2m deficiency in mice leads to iron overload.2 Significantly, knock-out of the Hfe gene clearly confers the HH phenotype to mice.3,4

Although HFE mutations are clearly associated with iron overload, the marked variability of the phenotype among homozygous individuals for the same HFE mutations indicates that other environmental and genetic factors modify disease severity.5 Earlier reports show that defective numbers of peripheral lymphocytes and liver lymphocyte populations are associated with a more severe clinical expression of iron overload and damage in HH.6,7

Previously, we investigated the effect of total lymphocyte absence in iron overload by crossing β2m−/− mice, lacking all β2m-dependent MHC-I molecules,2 with mice deficient in recombinase activator gene 1 (Rag1) required for normal B- and T-lymphocyte development.8 Immunodeficient β2mRag1−/− mice develop iron overload and, unlike their single knock-out counterparts, when challenged with dietary iron loading, iron accumulation occurs not only in the liver but also massively in the pancreas and heart myocytes.9

In this report, we further investigate the possible involvement of β2m-dependent molecules and lymphocytes in iron regulation. We examine changes in iron metabolism in compound mutant HfeRag−/− and β2mRag1−/− mice placed on a standard diet and after dietary iron challenge.

Study design

All procedures were performed in accordance with guidelines of Canadian Council on Animal Care and approved by the Animal Care Committee of the Centre Hospitalier de l’Université de Montréal. Hfe−/− mice have been described previously.3 β2m−/− and Rag1−/− mice were purchased from Jackson Laboratories (Bar Harbor, ME). All mutant mice have been back-crossed a minimum of 5 times onto the C57BL/6 (B6) background. Compound mutants β2mRag1−/− and HfeRag1−/− were obtained as described.9 Mouse peripheral blood cells were screened by flow cytometry in a Coulter Epics Elite counter (Coulter, Hialeah, FL) for the absence of T and B lymphocytes, using anti-αβTCR (T-cell marker) and anti-CD45R/B220 (B-cell marker) antibodies (PharMingen, San Diego, CA), and were genotyped by polymerase chain reaction (PCR) for β2m and Hfe mutations. All animals were 8 weeks old at the beginning of the experiments. They were given a commercial diet (Teklad Global 18% protein rodent diet; Harlan Teklad, Madison, WI), or, when indicated, the same standard diet supplemented with 2.5% (wt/wt) carbonyl iron (Sigma Immunochemicals, St Louis, MO). Iron levels were measured by acid digestion of tissue samples followed by iron quantification by atomic absorption spectroscopy.9 For histology, tissue sections were stained with Prussian blue for ferric iron detection (iron stain kit; Sigma Immunochemicals).

Results and discussion

To investigate whether the exacerbation of iron loading in β2mRag1−\− mice is due to the absence of only Hfe or to other β2m-dependent molecules, we generated mice lacking both Hfe and Rag1 (HfeRag1−/− mice). It was expected that if the only β2m-dependent molecule involved in iron regulation was Hfe, the β2mRag1−/− phenotype would be recapitulated in HfeRag1−/− double mutants. Surprisingly, hepatic iron rose dramatically in HfeRag1−/− double mutants, whereas iron levels in the heart and pancreas were not statistically different from Hfe−/− single knockout mice (Table 1). The hepatic iron increment in HfeRag1−/− was significant (P < .01) when compared with Hfe−/− single knock-out mice. In contrast, liver iron stores remained similar in β2mRag1−/− compared with β2m−/− mice.

Table 1
Tissue iron concentration in mice fed a standard or iron-enriched diet (2.5% wt/wt carbonyl iron) for 3 months

In the heart, iron concentration in HfeRag1−/− double mutants was similar to Hfe single knock-out mice (Table 1). In marked contrast, cardiac iron was significantly higher in β2mRag1−/− compared with β2m−/− mice (P < .01) or to the remaining mouse strains (P < .0005). Similarly, in the pancreas, HfeRag1−/− did not differ from Hfe−/− mice, whereas β2mRag1−/− mice showed a 3.7-fold increase in iron concentration over β2m−/− single knockout mice (P < .0001) and all other mouse strains. Thus, on a standard diet, the phenotype of HfeRag1−/− mice is strikingly different from that of β2mRag1−/−, the main difference being the affected organs where introduction of the Rag1 mutation leads to augmented iron loading.

To further investigate the responses to dietary iron loading in compound mutants, mice were challenged with a 2.5% wt/wt carbonyl iron-supplemented diet for 3 months. In the liver, the highest iron concentration was found in HfeRag1−/− mice, followed by Hfe−/−, β2mRag1−/−, and β2m−/− mice (Table 1). In the heart and pancreas, β2mRag1−/− mice accumulated more iron than any other mouse strains. These differences were highly significant (P < .0001 and P < .01, respectively, in the heart and pancreas). Iron accumulation was visible in β2mRag1−/− cardiac myocytes and pancreas sections stained with Prussian blue but remained undetectable in HfeRag1−/− mice (Figure 1).

Figure 1
Storage of excess iron in the heart and pancreas of mice after 3 months on a diet supplemented with 2.5% wt/wt carbonyl iron (Prussian blue staining, n = 5)

Thus, the observed phenotype differences between mice lacking both Hfe and Rag1 and mice lacking β2m and Rag1 persist and are even enhanced after dietary iron challenge. The differences in phenotype are likely due to the lack of other molecules that interact with β2m in β2m-deficient mice. Involvement of other β2m-dependent molecules in iron regulation has previously been suggested by the demonstration of increased hepatic iron in Hfeβ2m double-mutant mice compared with single knock outs10 and by the finding that MHC-I–deficient mice have elevated hepatic iron.11 Intriguingly, the phenotype of β2mRag1 double-deficient mice considerably resembles juvenile hemochromatosis (JH) in humans12 and hepcidin-deficient mice13 in the severity of iron overload and the involvement of the heart and pancreas. JH is an autosomal recessive disorder, which leads to early-onset, severe iron overload. Heart failure and endocrine manifestations are the most prominent clinical features of JH, whereas liver involvement, although present, is clinically less relevant. Iron accumulation in the liver of hepcidin-deficient mice is not particularly different from Hfe−/− or β2m−/− mice but rises dramatically in the pancreas and heart.13

In Hfe-deficient mice, hepatic hepcidin mRNA is inappropriately low, and the mice show a blunted response to iron loading.1416 However, β2m-deficient mice have higher hepcidin levels than healthy mice, which is an appropriate, although insufficient response to iron loading.17 A possible explanation for this difference may reside in the fact that β2m−/− mice are known to be functionally “leaky,” as residual functional MHC-I expression can still be detected.18,19 By analogy, residual Hfe expression may occur in β2m-deficient mice, giving them limited control over iron-induced hepcidin expression. This finding may explain why Hfe−/− and HfeRag1−/− mice accumulate more iron in the liver than do β2m−/− and β2mRag1−/− mice, respectively.

Accumulating evidence suggests that iron does not directly regulate hepcidin expression in hepatocytes17,20 and that hepcidin levels may be indirectly regulated by other cells. In fact, hepcidin expression can be induced by interleukin 6 (IL-6),20 a cytokine synthesized predominantly by macrophages and lymphocytes. Thus, lymphocytes may interfere with hepcidin regulation either directly, by secreting IL-6, or indirectly, through effects on macrophage differentiation and function.21 Alternatively, the fact that phenotype differences between Hfe- and β2m-deficient mice are evident only after lymphocyte depletion may indicate that lymphocytes represent an important iron storage compartment.

Phenotype differences between HfeRag1−/− and β2mRag1−/− mice may be attributable to the existence of other β2m-dependent, MHC-I–like molecules involved in iron regulation. Hfe is predominantly expressed in the liver, with the highest levels of Hfe mRNA found in hepatocytes.22,23 This is consistent with the finding that Hfe deletion primarily affects the liver. Presumably other β2m-dependent molecules might be more relevant in the heart and pancreas, which also express hepcidin.24

In conclusion, the work presented here suggests that alterations in the expression of β2m-dependent, MHC-I–like molecules and lymphocyte numbers may relate to phenotype variation in HH patients.


We thank Christian Dallaire for his help with atomic absorption spectroscopy, F. Arosa and B. Fournier for valuable discussions, and Ovid Da Silva for his editorial assistance.

Supported by a grant from the Canadian Institutes of Health Research (CIHR; grant no. MOP44045), and the Fundação para a Ciência e a Tecnologia (FCT; grant no. CBO/33485/99-00). M.M.S. is the recipient of a CIHR New Investigator award. N.C.A. is an Associate Investigator of the Howard Hughes Medical Institute.


1. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399–408. [PubMed]
2. Santos M, Schilham MW, Rademakers LH, et al. Defective iron homeostasis in beta 2-microglobulin knockout mice recapitulates hereditary hemochromatosis in man. J Exp Med. 1996;184:1975–1985. [PMC free article] [PubMed]
3. Levy JE, Montross LK, Cohen DE, Fleming MD, Andrews NC. The C282Y mutation causing hereditary hemochromatosis does not produce a null allele. Blood. 1999;94:9–11. [PubMed]
4. Zhou XY, Tomatsu S, Fleming RE, et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci U S A. 1998;95:2492–2497. [PubMed]
5. Olynyk JK, Cullen DJ, Aquilia S, et al. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med. 1999;341:718–724. [PubMed]
6. Porto G, Vicente C, Teixeira MA, et al. Relative impact of HLA phenotype and CD4-CD8 ratios on the clinical expression of hemochromatosis. Hepatology. 1997;25:397–402. [PubMed]
7. Cardoso EM, Hagen K, de Sousa M, Hultcrantz R. Hepatic damage in C282Y homozygotes relates to low numbers of CD8+ cells in the liver lobuli. Eur J Clin Invest. 2001;31:45–53. [PubMed]
8. Mombaerts P, Iacomini J, Johnson RS, et al. RAG-1-deficient mice have no mature B and T lymphocytes. Cell. 1992;68:869–877. [PubMed]
9. Santos MM, de Sousa M, Rademakers LH, et al. Iron overload and heart fibrosis in mice deficient for both beta2-microglobulin and Rag1. Am J Pathol. 2000;157:1883–1892. [PubMed]
10. Levy JE, Montross LK, Andrews NC. Genes that modify the hemochromatosis phenotype in mice. J Clin Invest. 2000;105:1209–1216. [PMC free article] [PubMed]
11. Cardoso EM, Macedo MG, Rohrlich P, et al. Increased hepatic iron in mice lacking classical MHC class I molecules. Blood. 2002;100:4239–4241. [PubMed]
12. Camaschella C, Roetto A, De Gobbi M. Juvenile hemochromatosis. Semin Hematol. 2002;39:242–248. [PubMed]
13. Nicolas G, Bennoun M, Devaux I, et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci U S A. 2001;98:8780–8785. [PubMed]
14. Ahmad KA, Ahmann JR, Migas MC, et al. Decreased liver hepcidin expression in the Hfe knockout mouse. Blood Cells Mol Dis. 2002;29:361–366. [PubMed]
15. Bridle KR, Frazer DM, Wilkins SJ, et al. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet. 2003;361:669–673. [PubMed]
16. Muckenthaler M, Roy CN, Custodio AO, et al. Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis. Nat Genet. 2003;34:102–107. [PubMed]
17. Pigeon C, Ilyin G, Courselaud B, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem. 2001;276:7811–7819. [PubMed]
18. Raulet DH. MHC class I-deficient mice. Adv Immunol. 1994;55:381–421. [PubMed]
19. Schell TD, Mylin LM, Tevethia SS, Joyce S. The assembly of functional beta(2)-microglobulin-free MHC class I molecules that interact with peptides and CD8(+) T lymphocytes. Int Immunol. 2002;14:775–782. [PubMed]
20. Nemeth E, Valore EV, Territo M, et al. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003;101:2461–2463. [PubMed]
21. Doherty TM. T-cell regulation of macrophage function. Curr Opin Immunol. 1995;7:400–404. [PubMed]
22. Holmstrom P, Dzikaite V, Hultcrantz R, et al. Structure and liver cell expression pattern of the HFE gene in the rat. J Hepatol. 2003;39:308–314. [PubMed]
23. Zhang AS, Xiong S, Tsukamoto H, Enns CA. Localization of iron metabolism–related mRNAs in rat liver indicate that HFE is expressed predominantly in hepatocytes. Blood. 2004;103:1509–1514. [PubMed]
24. Ilyin G, Courselaud B, Troadec MB, et al. Comparative analysis of mouse hepcidin 1 and 2 genes: evidence for different patterns of expression and co-inducibility during iron overload. FEBS Lett. 2003;542:22–26. [PubMed]